アレルギー疾患治療薬の世界市場インサイト、2030年までの予測

Global Targeted Drugs for Allergic Diseases Market Insights, Forecast to 2030

アレルギー疾患治療薬の世界市場は、2024年の371億4,912万米ドルから2030年には910億6,996万米ドルに成長すると予測され、予測期間中の年間平均成長率（CAGR）は16.12%である。米国とカナダのアレルギー疾患治... もっと見る

出版社	出版年月	電子版価格	言語
QYResearch QYリサーチ	2024年2月22日	US$4,900 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

アレルギー疾患治療薬の世界市場は、2024年の371億4,912万米ドルから2030年には910億6,996万米ドルに成長すると予測され、予測期間中の年間平均成長率（CAGR）は16.12%である。
米国とカナダのアレルギー疾患治療薬市場は、2024年の248億1,798万ドルから2030年には474億4,929万ドルに達すると推定され、2025年から2030年までの予測期間中のCAGRは11.41%である。
アレルギー疾患治療薬の中国市場は、2024年の230億3,336万ドルから2030年には165億2,416万ドルに達すると推定され、2025年から2030年の予測期間中のCAGRは38.88%である。
アレルギー疾患向け標的薬の欧州市場は、2024年の65億9,313万ドルから2030年には157億4,486万ドルに達すると推定され、2025年から2030年の予測期間中のCAGRは15.56%である。
アレルギー疾患用標的薬の世界の主要企業には、サノフィ、アッヴィ、ノバルティス、インサイト、ロシュ、アストラゼネカ、GSK、イーライリリー・アンド・カンパニー、アムジェン、ファイザー、レオ・ファーマ、テバ、大塚製薬、マブファームなどが含まれる。2023年、世界の上位5社の売上高シェアは約75.25%であった。

レポートの内容
アレルギー疾患向け標的薬の世界市場規模を概観します。2019年～2023年の過去の市場収益データ、2024年の推定値、2030年までのCAGR予測による世界市場動向の分析。
アレルギー疾患用標的薬の主要生産者を調査し、主要地域・国の収益も掲載しています。アレルギー疾患治療薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに分類して予測するための主要地域/国の注目点をハイライトしています。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、2019年から2024年までのデータで、アレルギー疾患向け標的薬の収益、市場シェア、主要企業の業界ランキングに焦点を当てています。世界のアレルギー疾患向け標的薬市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。

本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。アレルギー疾患向け標的薬の収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
サノフィ、ノバルティス、GSK、アムジェン、アストラゼネカ、ファイザー、TEVA、大塚製薬、ロシュなど、世界の主要企業の詳細な企業プロフィール。

市場セグメンテーション
企業別
サノフィ
アッヴィ
ノバルティス
インサイト
ロシュ
アストラゼネカ
GSK
イーライリリー・アンド・カンパニー
アムジェン
ファイザー
レオ・ファーマ
テバ
大塚製薬
マブファーム
キーメッドバイオサイエンス
ジェネリックス・バイオ
ドラゴンボート製薬
江蘇恒瑞医薬有限公司
サンシャイン国健
Qyunsセラピューティクス
バイオシオン

タイプ別セグメント
IL-4R
TSLP
IL-5
JAK
IgE
IL-13
その他

用途別セグメント
アトピー性皮膚炎
喘息
鼻ポリープを伴う慢性副鼻腔炎
慢性閉塞性肺疾患
その他

地域別
北米
米国
カナダ
中国

アジア（中国を除く）
日本
韓国
東南アジア
インド
オーストラリア

ヨーロッパ
ドイツ
フランス
英国
ロシア
イタリア
その他

ラテンアメリカ
ブラジル
メキシコ
アルゼンチン
コロンビア
その他

中東・アフリカ
サウジアラビア
UAE
トルコ
その他

各章の概要
第1章：報告書のスコープ、各市場セグメント（製品タイプ、用途など）の市場規模、将来の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章アレルギー疾患治療薬の世界および地域レベルでの売上高各地域と主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。
第3章：アレルギー疾患治療薬の標的薬企業鈥の競争環境、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章：各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展の可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけるのに役立つ。
第5章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第6章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の収益。
第7章：ヨーロッパ：タイプ別、用途別、国別、セグメント別収益。
第8章：中国：タイプ別、用途別、セグメント別収益。
第9章：アジア（中国を除く）：タイプ別、用途別、地域別、各セグメントの収益。
第10章：中東、アフリカ、ラテンアメリカ：タイプ別、用途別、国別、セグメント別収益。
第11章：主要企業のプロフィールを掲載。製品概要や仕様、アレルギー疾患治療薬の売上高、売上総利益率、最近の開発状況など、市場における主要企業の基本的な状況を詳しく紹介している。
第12章アナリストの視点/結論

ページTOPに戻る

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1
1.2.2 IL-4R 3
1.2.3 TSLP 4
1.2.4 IL-5 5
1.2.5 JAK 6
1.2.6 IgE 7
1.2.7 IL-13 8
1.3 Market by Application 9
1.3.1 Global Targeted Drugs for Allergic Diseases Market Share by Application: 2019 VS 2023 VS 2030 10
1.3.2 Atopic Dermatitis 12
1.3.3 Asthma 12
1.3.4 Chronic Sinusitis with Nasal Polyps 13
1.3.5 Chronic Obstructive Pulmonary Disease 14
1.3.6 Others 15
1.4 Assumptions and Limitations 19
1.5 Study Objectives 20
1.6 Years Considered 21
2 Global Growth Trends 22
2.1 Global Targeted Drugs for Allergic Diseases Market Perspective (2019-2030) 22
2.2 Global Targeted Drugs for Allergic Diseases Growth Trends by Region 23
2.2.1 Global Targeted Drugs for Allergic Diseases Market Size by Region: 2019 VS 2023 VS 2030 24
2.2.2 Targeted Drugs for Allergic Diseases Historic Market Size by Region (2019-2024) 25
2.2.3 Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2025-2030) 26
2.3 Targeted Drugs for Allergic Diseases Market Dynamics 27
2.3.1 Targeted Drugs for Allergic Diseases Industry Trends 27
2.3.2 Targeted Drugs for Allergic Diseases Market Drivers 28
2.3.3 Targeted Drugs for Allergic Diseases Market Challenges 29
2.3.4 Targeted Drugs for Allergic Diseases Market Restraints 29
3 Competition Landscape by Key Players 30
3.1 Global Revenue Targeted Drugs for Allergic Diseases by Players 30
3.1.1 Global Targeted Drugs for Allergic Diseases Revenue by Players (2019-2024) 30
3.1.2 Global Targeted Drugs for Allergic Diseases Revenue Market Share by Players (2019-2024) 31
3.2 Global Targeted Drugs for Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 32
3.3 Global Key Players of Targeted Drugs for Allergic Diseases, Ranking by Revenue, 2022 VS 2023 VS 2024 33
3.4 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio 34
3.4.1 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio (CR5) 34
3.4.2 Global Top 5 Companies by Targeted Drugs for Allergic Diseases Revenue in 2023 35
3.5 Global Key Players of Targeted Drugs for Allergic Diseases Head office and Area Served 36
3.6 Global Key Players of Targeted Drugs for Allergic Diseases Product Type 36
3.7 Global Key Players Established Date of Targeted Drugs for Allergic Diseases 37
3.8 Mergers & Acquisitions, Expansion Plans 38
4 Targeted Drugs for Allergic Diseases Breakdown Data by Type 52
4.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Type (2019-2024) 52
4.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2025-2030) 53
5 Targeted Drugs for Allergic Diseases Breakdown Data by Application 55
5.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Application (2019-2024) 55
5.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2025-2030) 56
6 North America 58
6.1 North America Targeted Drugs for Allergic Diseases Market Size (2019-2030) 58
6.2 North America Targeted Drugs for Allergic Diseases Market Size by Type 58
6.2.1 North America Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 58
6.2.2 North America Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 59
6.2.3 North America Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 60
6.3 North America Targeted Drugs for Allergic Diseases Market Size by Application 60
6.3.1 North America Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 60
6.3.2 North America Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 61
6.3.3 North America Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 62
6.4 North America Targeted Drugs for Allergic Diseases Market Size by Country 62
6.4.1 North America Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030 62
6.4.2 North America Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) 63
6.4.3 North America Targeted Drugs for Allergic Diseases Market Share by Country (2025-2030) 63
6.4.4 United States 64
6.4.5 Canada 65
7 Europe 66
7.1 Europe Targeted Drugs for Allergic Diseases Market Size (2019-2030) 66
7.2 Europe Targeted Drugs for Allergic Diseases Market Size by Type 66
7.2.1 Europe Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 66
7.2.2 Europe Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 67
7.2.3 Europe Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 68
7.3 Europe Targeted Drugs for Allergic Diseases Market Size by Application 68
7.3.1 Europe Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 68
7.3.2 Europe Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 69
7.3.3 Europe Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 70
7.4 Europe Targeted Drugs for Allergic Diseases Market Size by Country 70
7.4.1 Europe Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030 70
7.4.2 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) 71
7.4.3 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) 71
7.4.4 Germany 73
7.4.5 France 73
7.4.6 U.K. 74
7.4.7 Italy 74
7.4.8 Russia 75
8 China 76
8.1 China Targeted Drugs for Allergic Diseases Market Size (2019-2030) 76
8.2 China Targeted Drugs for Allergic Diseases Market Size by Type 76
8.2.1 China Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 76
8.2.2 China Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 77
8.2.3 China Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 78
8.3 China Targeted Drugs for Allergic Diseases Market Size by Application 78
8.3.1 China Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 78
8.3.2 China Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 79
8.3.3 China Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 80
9 Asia (excluding China) 81
9.1 Asia Targeted Drugs for Allergic Diseases Market Size (2019-2030) 81
9.2 Asia Targeted Drugs for Allergic Diseases Market Size by Type 81
9.2.1 Asia Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 81
9.2.2 Asia Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 82
9.2.3 Asia Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 83
9.3 Asia Targeted Drugs for Allergic Diseases Market Size by Application 83
9.3.1 Asia Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 83
9.3.2 Asia Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 84
9.3.3 Asia Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 85
9.4 Asia Targeted Drugs for Allergic Diseases Market Size by Region 85
9.4.1 Asia Targeted Drugs for Allergic Diseases Market Size by Region: 2019 VS 2023 VS 2030 85
9.4.2 Asia Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) 86
9.4.3 Asia Targeted Drugs for Allergic Diseases Market Size by Region (2025-2030) 86
9.4.4 Japan 87
9.4.5 South Korea 88
9.4.6 Southeast Asia 88
9.4.7 India 89
9.4.8 Australia 89
10 Latin America 90
10.1 Latin America Targeted Drugs for Allergic Diseases Market Size (2019-2030) 90
10.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Type 90
10.2.1 Latin America Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 90
10.2.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 91
10.2.3 Latin America Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 92
10.3 Latin America Targeted Drugs for Allergic Diseases Market Size by Application 92
10.3.1 Latin America Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 92
10.3.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 93
10.3.3 Latin America Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 94
10.4 Latin America Targeted Drugs for Allergic Diseases Market Size by Country 94
10.4.1 Latin America Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030 94
10.4.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) 95
10.4.3 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) 95
10.4.4 Brazil 96
10.4.5 Mexico 97
10.4.6 Argentina 97
10.4.7 Colombia 98
11 Middle East & Africa 99
11.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size (2019-2030) 99
11.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type 99
11.2.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 99
11.2.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 100
11.2.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 101
11.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application 101
11.3.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 101
11.3.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 102
11.3.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 103
11.4 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country 103
11.4.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030 103
11.4.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) 104
11.4.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) 104
11.4.4 Saudi Arabia 105
11.4.5 UAE 106
11.4.6 Turkey 106
12 Key Players Profiles 107
12.1 Sanofi 107
12.1.1 Sanofi Company Details 107
12.1.2 Sanofi Business Overview 107
12.1.3 Sanofi Targeted Drugs for Allergic Diseases Introduction 108
12.1.4 Sanofi Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 110
12.1.5 Sanofi Recent Development 110
12.2 AbbVie 114
12.2.1 AbbVie Company Details 114
12.2.2 AbbVie Business Overview 115
12.2.3 AbbVie Targeted Drugs for Allergic Diseases Introduction 115
12.2.4 AbbVie Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 117
12.2.5 AbbVie Recent Development 118
12.3 Novartis 123
12.3.1 Novartis Company Details 124
12.3.2 Novartis Business Overview 124
12.3.3 Novartis Targeted Drugs for Allergic Diseases Introduction 125
12.3.4 Novartis Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 127
12.3.5 Novartis Recent Development 127
12.4 Incyte 134
12.4.1 Incyte Company Details 134
12.4.2 Incyte Business Overview 134
12.4.3 Incyte Targeted Drugs for Allergic Diseases Introduction 135
12.4.4 Incyte Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 138
12.4.5 Incyte Recent Development 138
12.5 Roche 141
12.5.1 Roche Company Details 141
12.5.2 Roche Business Overview 141
12.5.3 Roche Targeted Drugs for Allergic Diseases Introduction 143
12.5.4 Roche Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 145
12.5.5 Roche Recent Development 146
12.6 AstraZeneca 148
12.6.1 AstraZeneca Company Details 148
12.6.2 AstraZeneca Business Overview 149
12.6.3 AstraZeneca Targeted Drugs for Allergic Diseases Introduction 149
12.6.4 AstraZeneca Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 154
12.6.5 AstraZeneca Recent Development 154
12.7 GSK 158
12.7.1 GSK Company Details 158
12.7.2 GSK Business Overview 159
12.7.3 GSK Targeted Drugs for Allergic Diseases Introduction 160
12.7.4 GSK Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 161
12.7.5 GSK Recent Development 162
12.8 Eli Lilly and Company 166
12.8.1 Eli Lilly and Company Company Details 167
12.8.2 Eli Lilly and Company Business Overview 167
12.8.3 Eli Lilly and Company Targeted Drugs for Allergic Diseases Introduction 168
12.8.4 Eli Lilly and Company Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 170
12.8.5 Eli Lilly and Company Recent Development 170
12.9 Amgen 174
12.9.1 Amgen Company Details 174
12.9.2 Amgen Business Overview 175
12.9.3 Amgen Targeted Drugs for Allergic Diseases Introduction 176
12.9.4 Amgen Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 177
12.9.5 Amgen Recent Development 177
12.10 Pfizer 179
12.10.1 Pfizer Company Details 180
12.10.2 Pfizer Business Overview 180
12.10.3 Pfizer Targeted Drugs for Allergic Diseases Introduction 181
12.10.4 Pfizer Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 184
12.10.5 Pfizer Recent Development 184
12.11 Leo Pharma 188
12.11.1 Leo Pharma Company Details 188
12.11.2 Leo Pharma Business Overview 188
12.11.3 Leo Pharma Targeted Drugs for Allergic Diseases Introduction 189
12.11.4 Leo Pharma Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 191
12.11.5 Leo Pharma Recent Development 191
12.12 TEVA 193
12.12.1 TEVA Company Details 193
12.12.2 TEVA Business Overview 193
12.12.3 TEVA Targeted Drugs for Allergic Diseases Introduction 194
12.12.4 TEVA Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 195
12.12.5 TEVA Recent Development 196
12.13 Otsuka Pharmaceutical 197
12.13.1 Otsuka Pharmaceutical Company Details 197
12.13.2 Otsuka Pharmaceutical Business Overview 198
12.13.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Introduction 198
12.13.4 Otsuka Pharmaceutical Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 200
12.13.5 Otsuka Pharmaceutical Recent Development 200
12.14 Mabpharm 201
12.14.1 Mabpharm Company Details 201
12.14.2 Mabpharm Business Overview 202
12.14.3 Mabpharm Targeted Drugs for Allergic Diseases Introduction 203
12.14.4 Mabpharm Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 203
12.14.5 Mabpharm Recent Development 204
12.15 Keymed Biosciences 205
12.15.1 Keymed Biosciences Company Details 205
12.15.2 Keymed Biosciences Business Overview 205
12.15.3 Keymed Biosciences Targeted Drugs for Allergic Diseases Introduction 207
12.15.4 Keymed Biosciences Recent Development 208
12.16 Genrix Bio 209
12.16.1 Genrix Bio Company Details 209
12.16.2 Genrix Bio Business Overview 210
12.16.3 Genrix Bio Targeted Drugs for Allergic Diseases Introduction 211
12.16.4 Genrix Bio Recent Development 211
12.17 Dragon Boat Pharmaceutical 212
12.17.1 Dragon Boat Pharmaceutical Company Details 212
12.17.2 Dragon Boat Pharmaceutical Business Overview 212
12.17.3 Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Introduction 213
12.18 Jiangsu Hengrui Pharmaceuticals 214
12.18.1 Jiangsu Hengrui Pharmaceuticals Company Details 214
12.18.2 Jiangsu Hengrui Pharmaceuticals Business Overview 214
12.18.3 Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Introduction 215
12.18.4 Jiangsu Hengrui Pharmaceuticals Recent Development 217
12.19 Sunshine Guojian 218
12.19.1 Sunshine Guojian Company Details 218
12.19.2 Sunshine Guojian Business Overview 219
12.19.3 Sunshine Guojian Targeted Drugs for Allergic Diseases Introduction 219
12.19.4 Sunshine Guojian Recent Development 220
12.20 Qyuns Therapeutics 221
12.20.1 Qyuns Therapeutics Company Details 221
12.20.2 Qyuns Therapeutics Business Overview 222
12.20.3 Qyuns Therapeutics Targeted Drugs for Allergic Diseases Introduction 222
12.20.4 Qyuns Therapeutics Recent Development 223
12.21 Biosion 224
12.21.1 Biosion Company Details 224
12.21.2 Biosion Business Overview 225
12.21.3 Biosion Targeted Drugs for Allergic Diseases Introduction 225
12.21.4 Biosion Recent Development 226
13 Analyst's Viewpoints/Conclusions 227
14 Appendix 229
14.1 Research Methodology 229
14.1.1 Methodology/Research Approach 229
14.1.2 Data Source 232
14.2 Author Details 235
14.3 Disclaimer 235

ページTOPに戻る

Table of Contents

Summary

The global Targeted Drugs for Allergic Diseases market is projected to grow from US$ 37,149.12 million in 2024 to US$ 91,069.96 million by 2030, at a Compound Annual Growth Rate (CAGR) of 16.12% during the forecast period.
The US & Canada market for Targeted Drugs for Allergic Diseases is estimated to increase from $ 24,817.98 million in 2024 to reach $ 47,449.29 million by 2030, at a CAGR of 11.41% during the forecast period of 2025 through 2030.
The China market for Targeted Drugs for Allergic Diseases is estimated to increase from $ 2,303.36 million in 2024 to reach $ 16,524.16 million by 2030, at a CAGR of 38.88% during the forecast period of 2025 through 2030.
The Europe market for Targeted Drugs for Allergic Diseases is estimated to increase from $ 6,593.13 million in 2024 to reach $ 15,704.86 million by 2030, at a CAGR of 15.56% during the forecast period of 2025 through 2030.
The global key companies of Targeted Drugs for Allergic Diseases include Sanofi, AbbVie, Novartis, Incyte, Roche, AstraZeneca, GSK, Eli Lilly and Company, Amgen, Pfizer, Leo Pharma, Teva, Otsuka Pharmaceutical, Mabpharm etc. In 2023, the global top five players had a share approximately 75.25 % in terms of revenue.

Report Includes
This report presents an overview of global market for Targeted Drugs for Allergic Diseases market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Targeted Drugs for Allergic Diseases, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Targeted Drugs for Allergic Diseases, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Targeted Drugs for Allergic Diseases revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Targeted Drugs for Allergic Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Targeted Drugs for Allergic Diseases revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Novartis, GSK, Amgen, AstraZeneca, Pfizer, TEVA, Otsuka Pharmaceutical, and Roche, etc.

Market Segmentation
By Company
Sanofi
AbbVie
Novartis
Incyte
Roche
AstraZeneca
GSK
Eli Lilly and Company
Amgen
Pfizer
Leo Pharma
Teva
Otsuka Pharmaceutical
Mabpharm
Keymed Biosciences
Genrix Bio
Dragon Boat Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Sunshine Guojian
Qyuns Therapeutics
Biosion

Segment by Type
IL-4R
TSLP
IL-5
JAK
IgE
IL-13
Others

Segment by Application
Atopic Dermatitis
Asthma
Chronic Sinusitis with Nasal Polyps
Chronic Obstructive Pulmonary Disease
Others

By Region
North America
United States
Canada
China

Asia (excluding China)
Japan
South Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Russia
Italy
Other

Latin America
Brazil
Mexico
Argentina
Colombia
Other

Middle East & Africa
Saudi Arabia
UAE
Turkey
Other

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Targeted Drugs for Allergic Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Drugs for Allergic Diseases companies鈥 competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted Drugs for Allergic Diseases revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

QYResearch社はどのような調査会社ですか?

QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

アレルギー疾患治療薬の世界市場インサイト、2030年までの予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?